Journal article
Cerebral microbleeds and asundexian in non-cardioembolic ischemic stroke: Secondary analyses of the PACIFIC-STROKE randomized trial
Abstract
BACKGROUND AND AIMS: Cerebral microbleeds are magnetic imaging resonance (MRI) markers of hemorrhage-prone cerebral small vessel disease that predict future risk of ischemic stroke and intracranial hemorrhage (ICrH). There exist concerns about the net benefit of antithrombotic therapy in patients with microbleeds. We aimed to investigate the effects of an oral factor-XIa inhibitor (asundexian), that is hypothesized to inhibit thrombosis without …
Authors
Balali P; Hart RG; Smith EE; Saad F; Colorado P; Lemmens R; De Marchis GM; Caso V; Xu L; Heenan L
Journal
International Journal of Stroke, Vol. 19, No. 5, pp. 526–535
Publisher
SAGE Publications
Publication Date
June 2024
DOI
10.1177/17474930231216339
ISSN
1747-4930